HOOKIPA PHARMA INC (HOOK) Stock Income Statement
NASDAQ:HOOK - Nasdaq - US43906K2096 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.35M | 43.95M | 20.13M | 14.25M | 18.45M | |||
| Operating Expenses | 84.25M | 88.73M | 105.06M | 87.40M | 100.12M | |||
| Research and Development | 61.20M | 67.13M | 85.08M | 67.13M | 80.52M | |||
| Selling, General, and Administrative Expenses | 23.06M | 21.60M | 19.98M | 20.19M | 19.17M | |||
| Operating Income | -74.90M | -44.79M | -84.93M | -73.16M | -81.67M | |||
| Interest Income/Expense | 2.61M | 3.70M | 4.98M | 950.00K | -870.00K | |||
| Other Income/Expense | 4.41M | 4.15M | 11.51M | 7.52M | 6.88M | |||
| Non Recurring Items | -5.53M | -6.67M | -12.77M | N/A | N/A | |||
| Income Before Taxes | -73.42M | -43.61M | -81.21M | -64.69M | -75.66M | |||
| Income Tax | -106.00K | -106.00K | 368.00K | 230.00K | 0.00 | |||
| Net Income | -73.31M | -43.50M | -81.58M | -64.92M | -75.67M | |||
| EBITDA | -72.40M | -42.03M | -81.38M | -69.56M | -77.03M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.85 | -3.47 | -8.63 | -0.99 | -2.30 | |||
| Non GAAP EPS | -5.84 | -3.51 | -8.80 | -10.50 | -23.10 | |||
| Statistics | ||||||||
| Profit Margin | -784.01% | -98.99% | -405.29% | -455.58% | -410.14% | |||
| Operating Profit Margin | -801.02% | -101.91% | -421.92% | -513.40% | -442.66% | |||
All data in USD